By mimicking the actions of the naturally occurring hormone amylin, pramlintide complements insulin by regulating the appearance of glucose into the circulation after meals via three primary mechanisms of action:
slowing gastric emptying, suppressing inappropriate post-meal glucagon secretion, and increasing satiety
.
What drugs are amylin analogs?
| Drug Name Avg. Rating Reviews | Symlin (Pro) Generic name: pramlintide 9.8 4 reviews | SymlinPen 60 Generic name: pramlintide 10 1 review | SymlinPen 120 Generic name: pramlintide No reviews | Symlin Pen Generic name: pramlintide No reviews |
|---|
How do amylin analogs work?
It
inhibits the release of glucagon when eating
, slows food emptying from the stomach and curbs appetite. Amylin agonists mimic these functions and have been shown to significantly reduce weight, average long-term blood glucose values ( HbA1c ), and even insulin doses for insulin-taking diabetics.
Which of the following medications is a synthetic analog of human amylin?
Pramlintide
is a synthetic analogue of human amylin, a naturally occurring hormone made in pancreatic beta cells. It slows gastric emptying, suppresses postprandial glucagon secretion, and regulates food intake through centrally mediated appetite modulation.
Does amylin inhibit insulin?
Amylin
inhibits glucose-induced insulin secretion
in the rat pancreas.
What is amylin used for?
Amylin is a peptide hormone that is cosecreted with insulin from the pancreatic β-cell and is thus deficient in diabetic people. It inhibits glucagon secretion, delays gastric emptying, and acts as a satiety agent. Amylin replacement could therefore possibly improve glycemic control in some people with
diabetes
.
What are incretin drugs?
Incretin mimetics are a
relatively new group of injectable drugs for treatment of type 2 diabetes
. The drugs, also commonly known as glucagon-like peptide 1 (GLP-1) receptor agonists or GLP-1 analogues, are normally prescribed for patients who have not been able to control their condition with tablet medication.
When should you take pramlintide?
Pramlintide is usually given
just before each major meal
. If you skip a meal, you should also skip your pramlintide dose. Use a different place on your stomach or thigh each time you give the injection.
Which drug can interfere with how pramlintide works?
- 5-HTP (5-hydroxytryptophan)
- Accutane (isotretinoin)
- Altenol (acetaminophen)
- Aspirin Low Strength (aspirin)
- Avandia (rosiglitazone)
- Byetta (exenatide)
- Celebrex (celecoxib)
- Coreg (carvedilol)
What class of drug is amylin?
Amylin analogues, or
agonists
, are injectable drugs used in the treatment of both type 1 diabetes and type 2 diabetes These compounds are administered before meals, and work similarly to the hormone amylin. Amylin has a number of benefits in terms of weight loss and reducing blood glucose levels.
What are examples of DPP 4 inhibitors?
Medicines in the DPP-4 inhibitor class include
sitagliptin, saxagliptin, linagliptin, and alogliptin
.
What are the GLP-1 drugs?
- Dulaglutide (Trulicity), taken by injection weekly.
- Exenatide extended release (Bydureon), taken by injection weekly.
- Exenatide (Byetta), taken by injection twice daily.
- Semaglutide (Ozempic), taken by injection weekly.
- Semaglutide (Rybelsus), taken by mouth once daily.
What is the brand name for pramlintide?
Pramlintide (trade name
Symlin
) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca). Pramlintide is sold as an acetate salt.
What is C-peptide function?
It is well known that C-peptide fulfills an important function in
the synthesis of insulin
. After cleavage of proinsulin in the pancreatic β-cells, the 31-amino acid C-peptide is secreted into the portal circulation in equimolar concentrations with insulin.
Where is amylin made?
It is produced by a group of cells
in the pancreas
called beta cells. But beta cells secrete more than just insulin; they also secrete amylin.
What type of hormone is GLP 1?
Glucagon-like peptide 1 (GLP-1) is
a physiological incretin hormone
from the lower gastrointestinal tract, partially explaining the augmented insulin response after oral compared to intravenous glucose administration in normal humans.
